Live SupporterHub Pty Ltd

OnMarket | Interview with CEO, Anthony Owen

Fixed Priced Private PlacementType of Offer
26 Feb 19Offer Open
22 Mar 19Pay By
$1.00Price
Up to $500,000Size of Offer
$10,000 Minimum Investment
OnMarketLead Manager

 

Private Placement

This Private Placement offer is only open to Professional, Sophisticated and Experienced investors.  More information on how to qualify here.

 

OnMarket has a limited allocation.  Minimum application size of $10,000. The Company reserves the right to close the offer early. 

Problem

There are ~59,000 registered charities in Australia, yet +70-80% cannot afford a CRM/SRM solution

Yet these groups need it most to ensure they engage with donors and can get funded in a competitive environment

The charity and Not for Profit (NFP) sectors are becoming increasingly digital and social, yet many they lack the right solution to support their donor engagement and fundraising activities.  Current products

  • require $100k-$2m+ of implementation and consulting costs, can take months to implement and require significant human capital and training – leaving many charities to resort to spreadsheets
  • are clunky and outdated built on old legacy systems that are not flexible or user friendly and require constant updates
  • require multiple products to manage charity activities and the lack of integration between them.

A plug n play solution – the Xero of SRMs

SupporterHub provides a fully built central hub for all donor engagement. The platform is tailored for the NFP sector to directly support workflows and operations and provides relationship management tools required to support mass engagement. Crucially, SupporterHub

  • Does not require any expensive, mandatory implementation costs – saving ~$100k-$2m compared with alternative products
  • Processes donations, manage campaigns, manage data and gain deeper insights with predictive analytics
  • API integrates with other systems
  • Intuitive and user friendly, requiring minimal support and training so charities can put valuable time and donor money to where it is needed most

NFP sector is large and growing

 

Management team

  • Anthony Owen– Direct/CEO: Over 25 years’ experience across local and global digital media and technology companies. Anthony has experience in international markets working with partners – Microsoft, IBM Watson, Ingram Micro and AppDirect as well as directly with many large corporations and Fortune 500 companies
  • Brad Anderson – CTO: Ex-Amnesty International executive with 16 years’ IT experience and 6 years developing technology strategy for not for profit organisations across the world, and provides a deep understanding of the business, technical and financial challenges they face.
  • Peter McCormick –Director: Director and COO of SecureCo, a local market leading Cyber Security and Fintech cloud organisation. Over 15 years of sales leadership and operational experience with various telco and IT service providers. Previously General Manager of Sales in Ethan Group and NSW Sales Manager in AAPT
  • Paul Bird – Director: Founder and Managing Director of SecureCo. Also a co-founder of Homestar Finance (Mozo Non-Bank Lender of the Year 2017). Previously held senior strategic roles at PBL Media and Diageo.

Offer Summary

The offer is a private placement seeking to raise up to $500,000 by issuing convertible notes.

Table 1: Key Offer Stats

 

 

.

Discover investment opportunities here

Tap 'More Info' to get access to free research, all company releases, and invest instantly for shares.


IPO Live

Koligo Therapeutics Ltd ASX: KOL

Koligo Therapeutics Ltd
A revenue-generating regenerative medicine and 3D bioprinting company

 

Koligo Therapeutics Ltd (ASX: KOL) is a US biotechnology company focused on the development and commercialisation of a range of cell therapy, three-dimensional (3D) bioprinted tissue and other regenerative medicine products for serious unmet medical needs.  Koligo has successfully commercialised and has commenced selling its first cell therapy transplant product, Kyslecel™, for the treatment of chronic pancreatitis patients, generating $1.6 million in revenue from sales of this product. Koligo is also working on other transformative cell therapies for a range of indications, including type 1 diabetes, and other pancreatic diseases.

$0.20Price
Up to A$7 millionSize of Offer
25 Feb 19Offer Open
22 Mar 19Pay By
IPO OnMarket Bidding Closed

AXS Group Ltd ASX: AXS

AXS Group Ltd
Global software provider in the digitisation and automation of asset processing and reporting solutions.

 

 Offer closed via OnMarket.

 

AXS Group Limited (ASX Code: AXS) is an integrated software solution provider to the finance, insurance and funds sector. With over 40 clients in Australia, North America, Europe and Asia they are focussed on helping clients with their digital transformation, reducing time and cutting costs. The Company’s cloud based ARMnet platform currently is used to manage over $100 billion of assets and transactions that are accessible via smart phones, tablets or email from anywhere at any time.

$0.25Price
Up to A$3.5 millionSize of Offer
11 Oct 18Offer Open
08 Mar 19Pay By
IPO OnMarket Bidding Closed

Aust. Nutrition & Sports Ltd ASX: AN1

Aust. Nutrition & Sports Ltd
Developing, sourcing and branding high quality Australian made milk formula and nutrition products

 

Offer closed early via OnMarket.  Payments are now due by 5pm Friday 22 March.

 

Australian Nutrition & Sports Ltd (ASX: AN1) is focussed on the development, branding and distribution of its own high-quality milk formula, health and wellness products for sale in Australia, China, Hong Kong, with plans to expand into further Asian markets over time.  Currently focused on infant and adult milk formula products,  protein-based health and wellness nutritional supplements, the company has successfully commercialised a number of products in Hong Kong with distribution through ~350 pharmacies. Expansion into the Chinese market is supported by production agreements with export approved Australian manufacturers.    

$0.20Price
Up to A$8 millionSize of Offer
12 Mar 19Offer Open
22 Mar 19Pay By